Elisabeth KrugExecutive Director at Eli Lilly & CompanySpeaker
Profile
Dr. Elisabeth Krug is an Executive Director at Eli Lilly with over 30 years of experience in small and large molecule analytical development, spanning preclinical through BLA/NDA. A pharmaceutical biologist by training (University of Würzburg), she joined Lilly Hamburg in 1995 as an analytical scientist.After four years as a Black Belt, she earned her Master Black Belt in Six Sigma in 2010. She subsequently joined Lilly's large molecule analytical development group, including an interim assignment heading the bioassay development group. Throughout her career, Elisabeth has been responsible for defining and delivering the analytical control strategy supporting global regulatory submissions.
Agenda Sessions
Critical Quality Attributes in Modern Biopharmaceutical Development: From Established mAbs to Emerging Modalities
, 9:00amView Session